Introduction
The pressure inside your eye, also referred to as intraocular pressure (IOP), is a major risk factor for the development and progression of glaucoma. Just like your blood pressure, IOP tends to fluctuate throughout the day. But when it stays too high for an extended period of time, it may begin to damage your optic nerve and slowly take away your vision.
You might have heard that cannabis could help lower eye pressure in glaucoma. But does it actually work at night, when eye pressure often rises the most? This article will aim to unpack what current researchers have found so far.
What is glaucoma
Glaucoma isn’t like other eye conditions that cause pain or sudden vision changes. It usually sneaks up without noticeable symptoms early on. Its subtle progression is why glaucoma is considered the number one cause of permanent blindness worldwide, with most cases happening in Asia.1,12 Unfortunately, most people find out they have glaucoma after some of their vision has already become damaged.
This eye condition slowly damages the optic nerve, which sends visual information from your eye to your brain. 6 Over time, this damage can lead to vision loss, often starting with your side, or peripheral vision. Without treatment, some people may even lose their sight completely.
In 2020, glaucoma caused blindness in about 3.61 million people globally, and around 4.14 million others were impacted by vision impairment.9 These numbers highlight how important early diagnosis and treatment really are for preserving sight.
Understanding intraocular pressure fluctuations
Why intraocular pressure (IOP) matters
IOP is the pressure inside your eye created by the fluid that helps maintain your eye health and vision.3 While some pressure is necessary for function, too much can damage your optic nerve and cause you to develop glaucoma. Because of this, lowering and controlling IOP is the main focus of glaucoma treatment. What many people don’t realise is that eye pressure isn’t constant; it goes up and down throughout the day and night. These changes are called IOP fluctuations.
Normal vs high intraocular pressure
In most clinical settings, doctors consider the normal eye pressure to be between 10 and 21 mmHg, with numbers above 21mmHg being considered as high IOP.3 Eye pressure alone doesn’t tell the whole story. Some people have pressure readings above 21 mmHg and never develop glaucoma, while others get glaucoma even with completely normal pressure readings.11
Circadian rhythm of IOP
The pressure inside your eye normally rises and falls at specific times over a 24-hour cycle, which is influenced by your circadian rhythm.10 This is your body’s internal clock that regulates processes like sleep, body temperature, and even eye pressure. If you have glaucoma or someone you know does, this biological clock might become a hidden battle. IOP tends to increase during the night, especially when you are lying down to rest.7 This means your optic nerve, which might already be vulnerable to glaucoma, faces extra pressure night after night. The really frustrating part? These nighttime peaks can still damage your vision while you sleep, even if your eye pressure seems normal during daytime appointments. It’s like having a problem that only shows up when no one is looking.
Why nighttime IOP control is crucial
What researchers are discovering is that these IOP fluctuations might be just as important as the actual IOP numbers themselves.2 Protecting your vision isn’t just about lowering eye pressure during the waking hours; it’s about understanding and managing what happens throughout the 24-hour period. This is why exploring how cannabis might help during those vulnerable nighttime hours is so important. Managing IOP around the clock is vital to prevent further vision loss in glaucoma. If nighttime pressure is left uncontrolled, optic nerve damage can continue despite normal daytime readings. This is why researchers are interested in substances or treatments that can help keep IOP stable daily.
Cannabis and its effect on IOP
What is cannabis
According to the World Health Organisation, cannabis is the most commonly used illegal drug for recreational purposes, but most people don’t know that the cannabis plant has been used in medicine for thousands of years.5
More than 100 cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), are produced by the Cannabis sativa plant. THC is the main psychoactive ingredient that makes you feel “high”, while CBD is frequently used to treat pain or epilepsy.5 Although both compounds have therapeutic benefits, research is still ongoing to determine their full potential, especially when used together. Cannabis can be consumed in various ways, including smoking, vaping, or eating as edibles.
How does cannabis lower IOP
THC lowers eye pressure by binding to certain receptors in your eye. These include the CB1 and GPR18 receptors.8 Yet, how this exactly happens is still not clear to scientists.6 Interestingly, just putting cannabinoids directly on the eye won’t do the job; they have to be smoked, eaten, or injected into the body to work well.4
Cannabis effects on night-time IOP fluctuations
Currently, not much research is out there on how cannabis specifically affects eye pressure during the night. But here's what we do know:
- Cannabis can lower eye pressure: Some studies have shown that smoking THC could drop IOP by up to 25% in people with glaucoma.6 But these studies didn't look at whether cannabis actually prevents damage to optic nerve damage when it is most likely to occur
- How cannabis reaches the eye matters: When THC is taken orally, almost none of it actually gets to your eye; only 1-2% of the drug makes it there.5 The majority of it spreads throughout your body, which can cause more side effects than localised benefits for the eye
- The problem with nighttime protection: Cannabis lowers eye pressure for about three to four hours.4 Since most people sleep for around eight hours, this effect wears off well before the night is over. That means during the hours when eye pressure usually goes up, cannabis might not be helping, and you’re left without ongoing protection
Limitations of using cannabis
While cannabis can lower eye pressure, there are several major downsides to using it as a treatment for glaucoma.
Common side effects include
- You may feel dizzy
- Have trouble with your memory
- Experience some changes in mood
- Have altered senses such as seeing brighter colours
- Experience panic attacks
- Smoking cannabis may cause respiratory risks
Most people with glaucoma are older adults, and these side effects can make daily life harder instead of better.11 They can affect your ability to concentrate at work, remember important details, or even go about your daily tasks safely.
Tolerance and addiction
Using cannabis regularly can make it less effective in lowering eye pressure over time. Your body becomes used to it, meaning you would need to take higher doses to get the same effect on IOP. There’s also a risk of becoming dependent on it, which creates new health concerns alongside glaucoma.
Legal issues
In many places, it is illegal to consume or possess cannabis. This means that anyone who attempts to treat their glaucoma could face criminal charges. Even in cases where cannabis is allowed for medical usage, some employers may still ban its use, which could negatively affect your job and career.
Impractical treatment
Despite what research has indicated, it is not recommended to use cannabis to manage or treat glaucoma. To lower eye pressure effectively, you would need to consume large amounts of THC daily, which is basically being high all day, every day. 11 As a result, it would be difficult to function normally or take care of yourself and your family with this quantity.
Additionally, cannabis has been found to actually work against itself by reducing the blood supply your optic nerve needs to stay healthy. 4As a result, you might lower your IOP with cannabis, but if you’re “starving” your optic nerve blood flow, you could still end up with vision loss.
The final verdict about cannabis and nighttime IOP fluctuations
- Cannabis can reduce your eye pressure temporarily, but it simply does not last long enough to protect your optic nerve all night11
- Cannabis should not be used as a self-medication for glaucoma. Without a reliable treatment, you risk losing your eyesight. To determine which alternative treatment option is best for you, speak to your ophthalmologist
- To determine if cannabis can be used safely and effectively to manage intraocular pressure in glaucoma, particularly at night, further research must be done
Here is a clear, concise summary that captures the most important points from your article and stays fully connected to the content:
Summary / Key points
- Glaucoma is a leading cause of irreversible blindness, often progressing silently as high or fluctuating intraocular pressure (IOP) slowly damages the optic nerve
- IOP naturally rises at night, especially when lying down, and these nighttime peaks can continue to harm the optic nerve even when daytime pressures appear normal
- Cannabis—mainly its THC component—can temporarily lower IOP, typically by up to 25%, but only for 3–4 hours, far shorter than a full night’s sleep
- No strong evidence exists that cannabis can control night-time IOP fluctuations or protect the optic nerve during these vulnerable overnight hours
- Very little THC reaches the eye when taken orally, and higher doses increase whole-body side effects without improving eye benefits
- Using cannabis long-term is impractical and risky for glaucoma management due to:
- Cognitive and mood-related side effects
- Respiratory risks if smoked
- Tolerance and dependence
- Legal and occupational consequences
- Reduced optic nerve blood flow, which may worsen vision loss
- Overall: Cannabis is not a safe or effective night-time IOP treatment and should not be used to self-manage glaucoma. More research is needed, and patients should rely on evidence-based therapies recommended by ophthalmologists
References
- Chan EW, Li X, Tham Y-C, Liao J, Wong TY, Aung T, et al. Glaucoma in Asia: regional prevalence variations and future projections. Br J Ophthalmol [Internet]. 2016 [cited 2025 Jul 4]; 100(1):78–85. Available from: https://bjo.bmj.com/lookup/doi/10.1136/bjophthalmol-2014-306102.
- Kim JH, Caprioli J. Intraocular Pressure Fluctuation: Is It Important? J Ophthalmic Vis Res [Internet]. 2018 [cited 2025 Jul 4]; 13(2):170–4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905311/.
- Machiele R, Motlagh M, Zeppieri M, Patel BC. Intraocular Pressure. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 4]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532237/.
- Mack A, Joy J. MARIJUANA AND GLAUCOMA. In: Marijuana as Medicine? The Science Beyond the Controversy [Internet]. National Academies Press (US); 2000 [cited 2025 Jul 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK224386/.
- Bondok M, Nguyen AX-L, Lando L, Wu AY. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. Clin Ophthalmol [Internet]. 2024 [cited 2025 Jul 4]; 18:3529–56. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613704/.
- Lopez MJ, Nataneli N. Cannabis Use for Glaucoma and Associated Pain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 4]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK572112/.
- De Bernardo M, Borrelli M, Cembalo G, Rosa N. Intraocular Pressure Measurements in Standing Position with a Rebound Tonometer. Medicina (Kaunas) [Internet]. 2019 [cited 2025 Jul 4]; 55(10):701. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843247/.
- Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Invest Ophthalmol Vis Sci [Internet]. 2018 [cited 2025 Jul 4]; 59(15):5904–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295937/.
- Vision Loss Expert Group of the Global Burden of Disease Study, Bourne RRA, Jonas JB, Friedman D, Nangia V, Bron A, et al. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye [Internet]. 2024 [cited 2025 Jul 4]; 38(11):2036–46. Available from: https://www.nature.com/articles/s41433-024-02995-5.
- Ikegami K. Circadian rhythm of intraocular pressure. The Journal of Physiological Sciences [Internet]. 2024 [cited 2025 Jul 4]; 74(1):14. Available from: https://doi.org/10.1186/s12576-024-00905-8.
- Sun X, Xu CS, Chadha N, Chen A, Liu J. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? Yale J Biol Med [Internet]. 2015 [cited 2025 Jul 4]; 88(3):265–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553646/.
- Kang JM, Tanna AP. Glaucoma. Medical Clinics of North America [Internet]. 2021 [cited 2025 Jul 4]; 105(3):493–510. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0025712521000043.

